VANCOUVER, BC, Jan. 18, 2022 /CNW/ - NeutriSci International
Inc. ("NeutriSci" or the "Company") (TSXV: NU) (OTCQB:
NRXCF) (FSE: 1N9), an innovative technology company developing
products, licensing IP and technology for B2B partnerships and the
nutraceutical industry, is pleased to announce that it has shipped
another order that was placed by Tabletz LLC, via air freight to
Japan. The respective revenue will
be booked in the current quarter.
This order consists of several thousand 3-tab TABLETZ sticks,
including all 3 flavors - Mint, Lemon, and Berry. The TABLETZ
sticks will be placed in a nation-wide grocery chain, as well as a
convenience store chain, and Biopole, a retailer in Japan specializing in organic food sales,
cosmetics, and beauty products.
Glen Rehman, CEO of NeutriSci,
commented, "We are pleased see the success Tabletz is having with
the product and how well it is being received in Japan. We look forward to helping to build
upon the success Tabletz LLC is having."
The Company also announces that the non-brokered private
placement announced on September 10,
2021, which involved the issuance of 210,333 units (the
"Units") at a price of $0.15
per unit, closed on September 21,
2021. Each Unit consisted of one common share and one common
share purchase warrant, with each whole warrant entitling the
holder to acquire an additional common share of the Company at a
price of $0.15 until March 21, 2023. All securities issued in
connection with the financing are subject to a statutory hold
period expiring January 22,
2022.
About NeutriSci International Inc.
NeutriSci specializes in the innovation, production, and
formulation of nutraceutical products. Established in 2009,
NeutriSci's is building sustainable sales models with Convenience,
Chain Drug, and Mass Market and Supermarket retailers for its
products offering co-branding as well as private label
opportunities and contract manufacturing services. For more
information, please visit: www.neutrisci.com.
On Behalf of the Board of Directors of
NEUTRISCI INTERNATIONAL INC.
Glen Rehman
CEO
Tel: (403) 264-6320
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in policies of the TSX Venture
Exchange) accept responsibility for the adequacy or accuracy of
this release.
This news release may include forward-looking statements that
are subject to risks and uncertainties. All statements within,
other than statements of historical fact, are to be considered
forward-looking. Although the Company believes the
expectations expressed in such forward-looking statements are based
on reasonable assumptions, such statements are not guarantees of
future performance and actual results or developments may differ
materially from those in forward-looking statements. Factors
that could cause actual results to differ materially from those in
forward-looking statements include market prices, continued
availability of capital and financing, and general economic, market
or business conditions. There can be no assurances that such
statements will prove accurate and, therefore, readers are advised
to rely on their own evaluation of such uncertainties. We do
not assume any obligation to update any forward-looking statements
except as required under the applicable laws.
Statements in this press release have not been evaluated by
the Food and Drug Administration. Products or ingredients are
not intended to diagnose, treat, cure, or prevent any
disease.
SOURCE NeutriSci International Inc.